Your browser doesn't support javascript.
loading
Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria.
Iriemenam, Nnaemeka C; Ige, Fehintola A; Greby, Stacie M; Mpamugo, Augustine; Abubakar, Ado G; Dawurung, Ayuba B; Esiekpe, Mudiaga K; Thomas, Andrew N; Okoli, Mary U; Awala, Samuel S; Ugboaja, Blessing N; Achugbu, Chicago C; Odoh, Ifeanyichukwu; Nwatu, Felicia D; Olaleye, Temitope; Akayi, Loveth; Akinmulero, Oluwaseun O; Dattijo, Joseph; Onokevbagbe, Edewede; Okunoye, Olumide; Mba, Nwando; Agala, Ndidi P; Uwandu, Mabel; Aniedobe, Maureen; Stafford, Kristen A; Abimiku, Alash'le; Hamada, Yohhei; Swaminathan, Mahesh; Okoye, McPaul I; Steinhardt, Laura C; Audu, Rosemary.
Afiliação
  • Iriemenam NC; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Ige FA; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
  • Greby SM; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Mpamugo A; University of Maryland, Baltimore, Abuja, Nigeria.
  • Abubakar AG; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Dawurung AB; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Esiekpe MK; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Thomas AN; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Okoli MU; National Reference Laboratory, Nigeria Centre for Disease Control Abuja, Abuja, Nigeria.
  • Awala SS; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Ugboaja BN; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Achugbu CC; National Reference Laboratory, Nigeria Centre for Disease Control Abuja, Abuja, Nigeria.
  • Odoh I; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Nwatu FD; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Olaleye T; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Akayi L; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Akinmulero OO; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Dattijo J; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Onokevbagbe E; University of Maryland, Baltimore, Abuja, Nigeria.
  • Okunoye O; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Mba N; National Reference Laboratory, Nigeria Centre for Disease Control Abuja, Abuja, Nigeria.
  • Agala NP; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Uwandu M; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
  • Aniedobe M; Microbiology Department, Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
  • Stafford KA; University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Abimiku A; International Research Center of Excellence, Institute of Human Virology, Abuja, Nigeria.
  • Hamada Y; University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Swaminathan M; Institute for Global Health, University College London, London, United Kingdom.
  • Okoye MI; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Steinhardt LC; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Audu R; Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
PLoS One ; 17(4): e0266184, 2022.
Article em En | MEDLINE | ID: mdl-35363818
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pandemias / COVID-19 Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nigéria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pandemias / COVID-19 Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nigéria